Abstract
The high level of uric acid in blood distinguishes humans from other studied species of mammals. The reason behind this is the absence of the enzyme uricase, which is evolutionary determined. Today, hyperuricemia can be considered as a factor of “diseases of civilization.” However, uric acid can also have positive effects, because it intensifies cognitive processes. The high level of uric acid in blood probably facilitated the emergence of intellectually advanced primates. Later, it enhanced the human’s motivation for active work. In the present review, these points are substantiated using data by V.P. Efroimson on the role of hyperuricemia and gout in the development of genius, V.S. Rotenberg’s Search Activity Concept, and the R. Johnson’s hypothesis on the role of uric acid as a messenger when it is necessary to change the behavioral responses of animals upon transition to active feeding. The nonspecific activating role of hyperuricemia is the factor that links all three hypotheses together. In addition, the enhancement of cognitive functions and motivations in hyperuricemia has been confirmed in different population samples. The biochemical basis for such effects is the potential for uric acid synthesis in the central nervous system and the penetration of the blood-brain barrier by its precursors, the interrelations between the metabolism of uric acid in the central nervous system and the metabolism of catecholamines and dopamine, and the neuroprotective and antioxidative properties of uric acid.
Similar content being viewed by others
References
Acheson, R.M., Social class gradients and serum uric acid in males and females, Br. Med. J., 1969, vol. 4, pp. 65–67.
Acheson, R.M., Epidemiology of serum uric acid and gout: an example of the complexities of multifactorial causation, Proc. R. Soc. Med., 1970, vol. 63, no. 2, pp. 193–197.
Almeida, R.F., Cereser, V.H., Faraco, R.B., et al., Systemic administration of GMP induces anxiolyticlike behavior in rats, Biochem. Behav., 2010, vol. 96, no. 3, pp. 306–311.
Amaro, S., Planas, A.M., and Chamorro, A., Uric acid administration in patients with acute stroke: a novel approach to neuroprotection, Expert Rev. Neurother., 2008, vol. 8, no. 2, pp. 259–270.
Ames, B.N., Cathcart, R., Schwiers, E., and Hochstein, P., Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis, Proc. Natl. Acad. Sci. U.S.A., 1981, vol. 78, pp. 6858–6862.
Amorini, A.M., Petzold, A., Tavazzi, B., et al., Increase of uric acid and purine compounds in biological fluids of multiple sclerosis patients, Clin. Biochem., 2009, vol. 42, nos. 10–11, pp. 1001–1006.
Antoniou, K., Papadopoulou-Daifoti, Z., Hyphantis, T., et al., A detailed behavioral analysis of the acute motor effects of caffeine in the rat: involvement of adenosine A1 and A2A receptors, Psychopharmacology, 2005, vol. 183, no. 2, pp. 154–162.
Anumonye, A., Dobson, J.W., Oppenheim, S., and Sutherland, J.S., Plasma uric acid concentrations among Edinburgh business executives, JAMA, J. Am. Med. Assoc., 1969, vol. 208, pp. 1141–1144.
Becker, B.F., Towards the physiological function of uric acid, Free Rad. Biol. Med., 1993, vol. 14, no. 6, pp. 615–631.
Becker, B.F., Kastenbauer, S., and Ködel, U., Urate oxidation in CSF and blood of patients with inflammatory disorders of the nervous system, Nucleosides Nucleotides Nucleic Acids, 2004, vol. 23, nos. 8–9, pp. 1201–1204.
Betz, A.L., Identification of hypoxanthine transport and xanthine oxidase activity in brain capillaries, J. Neurochem., 1985, vol. 44, no. 2, pp. 574–579.
Bloch, S. and Brackenridge, C.J., Psychological, performance and biochemical factors in medical students under examination stress, J. Psychosom. Res., 1972, vol. 16, pp. 25–33.
Bolgova, I.V., Rovda, U.I., Minjaylova, N.N., et al., The results of analysis of medical-social anamnesis of children and youths with hyperuricemia, Mat’ Dita Kuzb., 2009, vol. 2, no. 37, pp. 37–40.
Bowman, G.L., Shannon, J., Freic, B., et al., Uric acid as a CNS antioxidant, Alzheimers Dis., 2010, vol. 19, no. 4, pp. 1331–1336.
Brooks, S.C., Linn J.J., and Disney, N., Serotonin, folic acid, and uric acid metabolism in the diagnosis of neuropsychiatric disorders, Biol. Psychiatry, 1978, vol. 13, no. 6, pp. 671–684.
Brooks, G.W. and Mueller, E., Serum urate concentrations among university professors; relation to drive, achievement, leadership, JAMA, J. Am. Med. Assoc., 1966, vol. 195, pp. 415–418.
Brouns, R., Wauters, A., van de Vijver, G., et al., Decrease in uric acid in acute ischemic stroke correlates with stroke severity, evolution and outcome, Clin. Chem. Lab. Med., 2010, vol. 48, no. 3, pp. 383–390.
Burnstock, G., Physiology and pathophysiology of purinergic neurotransmission, Physiol. Rev., 2007, vol. 87, pp. 659–797.
Burroni, M., Cenci, L., Cervini, C., et al., L’uricemia nell’eta pediatrica (sue interrelazioni con lo sviluppo mentale), Clin. Dietol., 1981, vol. 8, pp. 17–39.
Chen, T., Wang, M., Liang, Y., et al., A nucleoside-nucleotide mixture may reduce memory deterioration in old senescence-accelerated mice, J. Nutr., 2000, vol. 130, pp. 3085–3089.
Church, W.H. and Rappolt, G., Nigrostriatal catecholamine metabolism in guinea pigs is altered by purine enzyme inhibition, Exp. Brain Res., 1999, vol. 127, pp. 147–150.
Church, W.H. and Ward, V.L., Uric acid is reduced in the substantia nigra in Parkinson’s disease: effect on dopamine oxidation, Brain Res. Bull., 1994, vol. 33, no. 4, pp. 419–425.
Clark, D.A., Arnold, E.L., Foulds, E.L., et al., Serum urate and cholesterol levels in Air Force Academy cadets, Aviat. Space Env. Med., 1975, vol. 46, no. 8, pp. 1044–1048.
Collazos, J., Blanco, M.S., Guerra, E., et al., Sequential evaluation of serum urate concentrations in AIDS patients with infections of the central nervous system, Clin. Chem. Lab. Med., 2000, vol. 38, no. 12, pp. 1293–1296.
Crawley, J.N., Marangos, P.J., Paul, S.M., et al., Interaction between purine and benzodiazepine: inosine reverses diazepam-induced stimulation of mouse exploratory behavior, Science, 1981, vol. 211, no. 4483, pp. 725–727.
Dujmovic, I., Pekmezovic, T., Obrenovic, R., et al., Cerebrospinal fluid and serum uric acid levels in patients with multiple sclerosis, Clin. Chem. Lab. Med., 2009, vol. 47, no. 7, pp. 848–853.
Dunn, J.P., Brooks, G.W., Mausner, J., et al., Social class gradient of serum uric acid levels in males, JAMA, J. Am. Med. Assoc., 1963, vol. 185, pp. 431–436.
Dzhergeniia, S.L. and Ushakov, I.B., Results of experimental study of psychophysiological state and hematological characteristics in servicemen presenting with hyperuricemia, Vestn. Ross. Akad. Med. Nauk, 2010, no. 12, pp. 33–37.
Efroimson, V.P., Genetika genial’nosti (Genetics of Genius), Moscow: Taideks Ko., 2002.
Enrico, P., Mura, M.A., Esposito, G., et al., Effect of naloxone on morphine-induced changes in striatal dopamine metabolism and glutamate, ascorbic acid and uric acid release in freely moving rats, Brain Res., 1998, vol. 497, no. 1, pp. 94–102.
Essman, W.B., Purine metabolism in memory consolidations, in Convention of the American Association for the Advancement of Science, New York: Academic, 1967, pp. 1–12.
Euser, S.M., Hofman, A., Westendorp, R.G., and Breteler, M.M., Serum uric acid and cognitive function and dementia, Brain, 2009, vol. 132, pp. 377–382.
Fowler, M.G., Relationship of serum uric acid to achievement motivation, Psychosom. Med., 1973, vol. 35, no. 1, pp. 13–22.
Gao, X., Curhan, G., Forman, J.P., et al., Vitamin C intake and serum uric acid concentration in men, J. Rheumatol., 2008, vol. 35, no. 9, pp. 1853–1858.
George, J. and Struthers, A.D., Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress, Vasc. Health Risk Manage., 2009, vol. 5, pp. 265–272.
Golubovskii, M., Genius and genetics (V.P. Efroimson), 1999. http://www.vestnik.com/issues/1999/0316/win/golubov.htm
Gulbrandsen, C.L., Morton, N.E., Rao, D.C., et al., Determinants of plasma uric acid, Hum. Genet., 1979, vol. 50, no. 3, pp. 307–312.
Hartung, D., Stadeler, M., Grieshaber, R., et al., Work and diet-related risk factors of cardiovascular diseases: comparison of two occupational groups, J. Occup. Med. Tox., 2010, vol. 5, no. 4, pp. 1–8.
Hayden, M.R. and Tyagi, S.C., Uric acid: a new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: the urate redox shuttle, Nutr. Metab., 2004, vol. 1, pp. 1–10.
Hooper, D.C., Scott, G.S., Zborek, A., et al., Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis, FASEB J., 2000, vol. 14, pp. 691–698.
Hunter, R.E., Barrera, C.M., Dohanich, G.P., and Dunlap, W.P., Effects of uric acid and caffeine on A1 adenosine receptor binding in developing rat brain, Pharmacol. Biochem. Behav., 1990, vol. 35, no. 4, pp. 791–795.
Il’ina, A.E., Barskova, V.G., and Nasonov, E.L., Latent hyperuricemia-is benefit or harm? Russ. Med. Zh., 2008, vol. 16, no. 24, pp. 16–19.
Inouye, E., Park, K.S., and Asaka, A., Blood uric acid level and IQ: a study in twin families, Acta Genet. Med. Gemellol., 1984, vol. 33, no. 2, pp. 237–242.
Jenni, L., Jenni-Eiermann, S., Spina, F., and Schwabl, H., Regulation of protein breakdown and adrenocortical response to stress in birds during migratory flight, Am. J. Physiol., 2000, vol. 278, pp. R1182–R1189.
Johnson, R.J., Andrews, P., Benner, S.A., et al., The evolution of obesity: insights from the mid-Miocene, Trans. Am. Clin. Climatol. Assoc., 2010, vol. 121, pp. 295–307.
Johnson, R.J., Gaucher, E.A., Sautin, Y.Y., et al., The planetary biology of ascorbate and uric acid and their relationship with the epidemic of obesity and cardiovascular disease, Med. Hypotheses, 2008, vol. 71, no. 1, pp. 22–31.
Johnson, R.J., Sautin, Y.Y., Oliver, W.J., et al., Lessons from comparative physiology: could uric acid represent a physiologic alarm signal gone awry in western society?, J. Comp. Physiol., B, 2009, vol. 179, no. 1, pp. 67–76.
Joseph, M.H. and Hodges, H., Lever pressing for food reward and changes in dopamine turnover and uric acid in rat caudate and nucleus accumbens studied chronically by in vivo voltammetry, J. Neurosci. Meth., 1990, vol. 34, nos. 1–3, pp. 143–149.
Kasl, S.V., Brooks, G.W., and Cobb, S., Serum urate concentrations in male high-school students, JAMA, J. Am. Med. Assoc., 1966, vol. 198, no. 7, pp. 713–716.
Kasl, S.V., Brooks, G.W., and Rodgers, W.L., Serum uric acid and cholesterol in achievement behavior and motivation, JAMA, J. Am. Med. Assoc., 1970, vol. 213, pp. 1158–1164, 1291–1299.
Kastenbauera, S., Koedela, U., Beckerb, B.F., and Pfistera, H.W., Experimental meningitis in the rat: protection by uric acid at human physiological blood concentrations, Eur. J. Pharm., 2001, vol. 425, no. 2, pp. 149–152.
Katz, J.L. and Weiner, H., Psychosomatic considerations in hyperuricemia and gout, Psychosom. Med., 1972, vol. 34, no. 2, pp. 165–182.
Kennett, K.F. and Cropley, A.J., Uric acid and divergent thinking: a possible relationship, Br. J. Psychol., 1975, vol. 66, no. 2, pp. 175–180.
Kim, P., Yaksh, T.L., Burnett, P.C., et al., Cerebrospinal fluid levels of uric acid in dogs and the effect of allopurinol, Brain Res., 1987, vol. 402, no. 1, pp. 87–92.
Kutzing, M.K. and Firestein, B.L., Altered uric acid levels and disease states, J. Pharmacol. Exp. Ther., 2008, vol. 324, no. 1, pp. 1–7.
López-Jiménez, M., García Puig, J., and Mateos, A.F., Purine transport through the blood-brain barrier in hypoxanthine phosphoribosyltransferase deficiency, Med. Clin., 1989, vol. 92, no. 5, pp. 167–170.
Lorenzia, T.M., Borbaa, D.L., Dutraa, G., et al., Association of serum uric acid levels with emotional and affective temperaments, J. Aff. Dis., 2010, vol. 121, nos. 1–2, pp. 161–164.
Machado-Vieira, R., Salvadore, G., Diaz-Granados, N., et al., New therapeutic targets for mood disorders, Sci. World J., 2011, vol. 10, pp. 713–726.
Mattle, H.P., Lienert, C., and Greeve, I., Uric acid and multiple sclerosis, Ther Umsch., 2004, vol. 61, no. 9, pp. 553–555.
Mertz, D.P., Gout hazard as the price for development of intelligence? Dtsch. Med. Wochenschr., 1974, vol. 99, no. 1, pp. 24–26.
Montoye, H.J., Faulkner, J.A., Dodge, H.J., et al., Serum uric acid concentration among business executives, Ann. Int. Med., 1967, vol. 66, pp. 838–850.
Mueller, K., Voltammetric evidence in vivo of cholinergic modulation of extracellular ascorbic and uric acid in rat striatum, Brain Res., 1987, vol. 408, no. 1, pp. 313–316.
Mueller, K., The effects of haloperidol and amphetamine on ascorbic acid and uric acid in caudate and nucleus accumbens of rats as measured by voltammetry in vivo, Life Sci., 1990, vol. 47, no. 8, pp. 735–742.
Mueller, K., Palmour, R., and Andrews, C.D., In vivo voltammetric evidence of production of uric acid by rat caudate, Brain Res., 1985, vol. 335, no. 2, pp. 231–235.
Murray, R.K., Granner, D.K., Mayes, P.A., and Rodwell, V.W., Harper’s Biochemistry, Norwalk, CT: Appleton & Lange, 1990, vol. 2, 2nd ed.
Neill, O.R., Uric acid levels and dopamine transmission in rat striatum diurnal changes and effects of drug, Brain Res., 1990, vol. 507, no. 2, pp. 267–272.
Nomikos, G.G., Zis, A.P., Damsma, G., and Fibiger, H.C., Electroconvulsive shock increases interstitial concentrations of uric acid in the rat brain, Brain Res., 1994, vol. 660, no. 1, pp. 50–56.
Okamoto, I., Kayano, T., Hanaya, T., et al., Up-regulation of an extracellular superoxide dismutase-like activity in hibernating hamsters subjected to oxidative stress in mid- to late arousal from torpor, Comp. Biochem. Physiol., 2006, vol. 144, pp. 47–56.
Ooki, S., Yamada, K., and Asaka, A., Relationship between blood uric acid level and personality traits, Acta Genet. Med. Gemellol., 1990, vol. 39, no. 1, pp. 117–122.
Orowan, E., The origin of man, Nature, 1955, vol. 175, pp. 683–684.
Parmar, N., Uric acid and cardiovascular risk, N. Engl. J. Med., 2009, vol. 360, p. 5.
Popert, A.J. and Hewitt, J.V., Gout and hyperuricaemia in rural and urban populations, Ann. Rheum. Dis., 1962, vol. 21, pp. 154–163.
Puschel, G.P., Nath, A., and Jungermann, K., Increase of urate formation by stimulation of sympathetic hepatic nerves, circulating noradrenaline and glucagon in the perfused rat liver, FEBS Lett., 1987, vol. 219, no. 1, pp. 145–150.
Rahe, R.H., Rubin, R.T., and Arthur, R.J., The three investigators study. Serum uric acid, cholesterol, and cortisol variability during stresses of everyday life, Psychosom. Med., 1974, vol. 36, pp. 258–268.
Rathbone, M.P., Middlemiss, P.J., Gysbers, J.W., et al., Trophic effects of purines in neurons and glial cells, Progr. Neurobiol., 1999, vol. 59, no. 6, pp. 663–690.
Redzic, Z.B., Gasic, J.M., and Segal, M.B., The kinetics of hypoxanthine transport across perfused choroid plexus of the sheep, Brain Res., 2002, vol. 925, no. 2, pp. 169–175.
Reiber, H., Ruff, M., and Uhr, M., Ascorbate concentration in human cerebrospinal fluid (CSF) and serum. Intrathecal accumulation and CSF flow rate, Clin. Chim. Acta, 1993, vol. 217, no. 2, pp. 163–173.
Reyes, A.J., The increase in serum uric acid concentration caused by diuretics might be beneficial in heart failure, Eur. J. Heart Fail., 2005, vol. 7, no. 4, pp. 461–467.
Robin, J.P., Boucontet, L., Chillet, P., and Groscolas, R., Behavioral changes in fasting emperor penguins: evidence for a “refeeding signal” linked to a metabolic shift, Am. J. Physiol., 1998, vol. 274, pp. R746–R753.
Rotenberg, V.S., Snovedeniya, gipnoz i deyatel’nost’ mozga (Dreams, Hypnosis, and Brain Activity), Moscow: Tsentr Gumanitarn. Liter. RON, 2001.
Rovda, Yu.I., Igisheva, L.N., and Kazakova, L.M., Influence of serums with different uric acid concentration in youths with hyperuricemia on electric characteristics of mollusk, Pediatriya, 1993, no. 6, pp. 40–44.
Rovda, Yu.I. and Kazakova, L.M., Purinosis (gouty diathesis) and some diseases of children and adults (urate nephropathy, gout, arterial hypertension, obesity, metabolic syndrome, pancreatic diabetes), Mat’ Dita Kuzb., 2003, vol. 15, no. 4, pp. 18–22.
Sakamoto, K., Takao, F., and Yoshimoto, S., An epidemiologic study on the correlation between salt threshold, academic test marks, biochemical data, number of complaints, and personality in women college students, Am. J. Prev. Med., 1986, vol. 2, no. 6, pp. 351–358.
Schmidt, A.P., Böhmer, A.E., Antunes, C., et al., Antinociceptive properties of the xanthine oxidase inhibitor allopurinol in mice: role of A1 adenosine receptors, Br. J. Pharmacol., 2009, vol. 156, no. 1, pp. 163–172.
Scott, G.S., Spitsin, S.V., Kean, R.B., et al., Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors, Proc. Natl. Acad. Sci. U.S.A., 2002, vol. 99, no. 25, pp. 16303–16308.
Sevanian, A., Davies, K.J., and Hochstein, P., Serum urate as an antioxidant for ascorbic acid, Am. J. Clin. Nutr., 1991, vol. 54, no. 6, pp. 1129S–1134S.
Skolnick, P., Paul, S.M., and Marangos, P.J., Purines as endogenous ligands of the benzodiazepine receptor, Fed. Proc., 1980, vol. 39, no. 12, pp. 3050–3055.
Sofaer, J. and Emery, A., Genes for super-intelligence?, J. Med. Genet., 1981, vol. 18, pp. 410–413.
Stetten D., Jr., and Hearon, J.Z., Intellectual level measured by army classification battery and serum uric acid concentration, Science, 1959, vol. 3365, no. 129, p. 1737.
Stevens, H.A., Cropley, A.J., and Blattler, D.P., Intellect and serum uric acid: an optimal concentration of serum urate for human learning? Soc. Biol., 1975, vol. 22, no. 3, pp. 229–234.
Tan, S., Radi, R., Gaudier, F., et al., Physiologic levels of uric acid inhibit xanthine oxidase in human plasma, Pediatr. Res., 1993, vol. 34, no. 3, pp. 303–307.
Titov, V.N., Dmitriev, V.A., Gushchina, O.V., et al., Physicochemical activity of uric acid. Hyperuricemia as an impaired biological function of endoecology and adaptation, biological reactions of excretion, inflammation, and hydrodynamic arterial pressure, Usp. Sovrem. Biol., 2011, no. 5, pp. 483–502.
Toshihiko, A., Masahico, Y., and Takeo, I., Postmorterm changes of uric acid in various rat tissues: determination of uric acid by reversed phase HPLC with electrochemical detection, Anal. Biochem., 1984, vol. 143, no. 1, pp. 113–118.
Ueda, T., Kinoshita, K., Wakisaka, S., and Adachi, H., Clinical value of the sequential study of the uric acid level in the CSF in patients with postoperative meningitis, No Shinkei Geka, 1985, vol. 13, no. 7, pp. 719–724.
Vasdev, S., Gill, V., Parai, S., et al., Dietary vitamins E and C supplementation prevents fructose induced hypertension, Mol. Cell. Biochem., 2002, vol. 241, pp. 107–114.
Villegas, R., Xiang, Y., Cai, Q., et al., Prevalence and determinants of hyperuricemia in middle-aged, urban chinese men, Met. Syn. Rel. Dis., 2010, vol. 8, no. 3, pp. 263–270.
Wagner, J.A. and Katz, R.J., Purinergic control of anxiety: direct behavioral evidence in the rat, Neurosci. Lett., 1983, vol. 43, nos. 2–3, pp. 333–337.
Wallage, S.L., Chase, P.H., and Ellman, A., Birth order in gout, Arthr. Rheumatol., 1967, vol. 10, no. 4, p. 368.
Waring, W.S., McKnight, J.A., Webb, D.J., and Maxwell, S.R., Uric acid restores endothelial function in patients with type 1 diabetes and regular smokers, Diabetes, 2006, vol. 55, pp. 3127–3132.
Watanabe, S., Kang, D.H., Feng, L., et al., Uric acid, hominoid evolution, and the pathogenesis of saltsensitivity, Hypertension, 2002, vol. 40, no. 3, pp. 355–360.
Yanai, H. and Morimoto, M., Effect of ascorbate on serum lipids and urate metabolism during exhaustive training, Clin. Sci., 2004, vol. 106, no. 1, pp. 107–109.
Yiginer, O., Ozcelik, F., Inanc, T., et al., Allopurinol improves endothelial function and reduces oxidant-inflammatory enzyme of myeloperoxidase in metabolic syndrome, Clin. Res. Cardiol., 2008, vol. 97, no. 5, pp. 334–340.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © O.V. Tovchiga, S.Yu. Shtrygol’, 2013, published in Zhurnal Obshchei Biologii, 2013, Vol. 74, No. 4, pp. 268–282.
Rights and permissions
About this article
Cite this article
Tovchiga, O.V., Shtrygol’, S.Y. Uric acid and central nervous system functioning (a literature review). Biol Bull Rev 4, 210–221 (2014). https://doi.org/10.1134/S2079086414030086
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S2079086414030086